How can we help?
For advertising queries please email [email protected] or for further information visit our Advertise page
For editorial queries please email [email protected] or for further information visit our Contribute page
Newsletters and Deep Dive digital magazine
For advertising queries please email [email protected] or for further information visit our Advertise page
For editorial queries please email [email protected] or for further information visit our Contribute page
Ahead of an opt-in decision on a PCSK9 inhibitor candidate, Eli Lilly is reported to be in advanced takeover negotiations with Verve Therapeutics.
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Developments in the oncology space in 2024 brought hope to both industry and patients.
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Improving Global Access to Life-Changing Therapeutics...